About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Understanding Challenges and Needs in Refractory Chronic GVHD
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
G
Steroid-Refractory GvHD Management: When to Switch From Steroids
By
Giuseppe Francesco Milone
52 views
August 1, 2024
0 Comments
Login to view comments.
Click here to Login
06:18
Robert Zeiser
CSF1R's Role in Modulating Inflammation and Fibrosis in cGVHD
23:37
Rush University Medical Center
Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6
Feat.
E. Bhaimia
46:03
University of Colorado Cancer Center
CAR NK Cells: Next Generation Cell Therapies for Cancer
Feat.
K. Rezvani
08:08
Jose Perez Simon
Unmet Needs in GvHD and the Role of Axatilimab
08:43
Nandita Khera
Maintaining QoL in Chronic GvHD
17:18
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Approaches to Preventing and Treating GVHD in 2024
Feat.
N. Hossain
14:19
Zachariah DeFilipp
Axatilimab in Chronic GVHD: Updates From the AGAVE-201 Study
27:21
UChicago Medicine
Updates in Transplantation and GVHD From Recent Meetings
Feat.
M. Nawas
31:53
Indy Hematology Review
HSCT in 2024: What Every Hematologist Needs to Know
Feat.
R. Childs
10:54
Insights from 2023 ASH Annual Meeting
Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Dos…
Feat.
D. Wolff
14:54
Insights from 2023 ASH Annual Meeting
Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has…
Feat.
J. Schetelig